Selective serotonin reuptake inhibitors (SSRIs) are among the most commonly prescribed psychiatric medications worldwide. While they have proven beneficial for many individuals, their effectiveness is not universal.
Experts have raised alarms regarding the potential overprescription of these drugs, suggesting that some patients may not receive the appropriate treatment for their conditions.
As discussions around mental health continue to evolve, it is crucial to consider the implications of prescribing practices and ensure that patients receive tailored care.